DIN 02533987 — QULIPTA 30 MG
QULIPTA is a tablet of Atogepant marketed by ABBVIE CORPORATION. The full Atogepant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02533987
- Brand name
- QULIPTA
- Active ingredient
- Atogepant
- Strength
- 30 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Calcitonin gene-related peptide (CGRP) receptor antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atogepant products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02533979 | QULIPTA | 10 MG | TABLET | ABBVIE CORPORATION | MARKETED |
| 02533995 | QULIPTA | 60 MG | TABLET | ABBVIE CORPORATION | MARKETED |